{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:08:20Z","timestamp":1790118500694,"version":"4.0.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-59498-4","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:45:34Z","timestamp":1782488734000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u201cMolecular insights into the synergistic anticancer effect of stigmasterol and cabazitaxel in colon cancer through ROS-mediated mitochondrial dysfunction and apoptosis\u201d"],"prefix":"10.1038","volume":"16","author":[{"given":"Pooja","family":"Goswami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nivedita","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreyans Kumar","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anup","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biplob","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"59498_CR1","doi-asserted-by":"publisher","first-page":"101839","DOI":"10.1016\/j.bpg.2023.101839","volume":"66","author":"L Klimeck","year":"2023","unstructured":"Klimeck, L., Heisser, T., Hoffmeister, M. & Brenner, H. Colorectal cancer: A health and economic problem. Best Pract. Res. Clin. Gastroenterol. 66, 101839. https:\/\/doi.org\/10.1016\/j.bpg.2023.101839 (2023).","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"issue":"2","key":"59498_CR2","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1053\/j.gastro.2019.07.055","volume":"158","author":"EM Stoffel","year":"2020","unstructured":"Stoffel, E. M. & Murphy, C. C. Epidemiology and Mechanisms of the Increasing Incidence of Colon and Rectal Cancers in Young Adults. Gastroenterology 158 (2), 341\u2013353. https:\/\/doi.org\/10.1053\/j.gastro.2019.07.055 (2020).","journal-title":"Gastroenterology"},{"issue":"3","key":"59498_CR3","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.clcc.2022.05.006","volume":"21","author":"JC Fabregas","year":"2022","unstructured":"Fabregas, J. C., Ramnaraign, B. & George, T. J. Clinical Updates for Colon Cancer Care in 2022. Clin. Colorectal Cancer. 21 (3), 198\u2013203. https:\/\/doi.org\/10.1016\/j.clcc.2022.05.006 (2022).","journal-title":"Clin. Colorectal Cancer"},{"issue":"3","key":"59498_CR4","doi-asserted-by":"publisher","first-page":"329","DOI":"10.6004\/jnccn.2021.0012","volume":"19","author":"AB Benson","year":"2021","unstructured":"Benson, A. B. et al. Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr. Canc Netw. 19 (3), 329\u2013359. https:\/\/doi.org\/10.6004\/jnccn.2021.0012 (2021).","journal-title":"J. Natl. Compr. Canc Netw."},{"issue":"2","key":"59498_CR5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1055\/s-0038-1676473","volume":"32","author":"Z Ven Fong","year":"2019","unstructured":"Ven Fong, Z. et al. Contemporary Opportunity for Prehabilitation as Part of an Enhanced Recovery after Surgery Pathway in Colorectal Surgery. Clin. Colon Rectal Surg. 32 (2), 95\u2013101. https:\/\/doi.org\/10.1055\/s-0038-1676473 (2019).","journal-title":"Clin. Colon Rectal Surg."},{"issue":"11","key":"59498_CR6","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1158\/1078-0432.CCR-12-3146","volume":"19","author":"P Vrignaud","year":"2013","unstructured":"Vrignaud, P. et al. Preclinical antitumor activity of cabazitaxel, a semisynthetic taxane active in taxane-resistant tumors. Clin. Cancer Res. 19 (11), 2973\u20132983. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-3146 (2013).","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"59498_CR7","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1002\/2211-5463.13290","volume":"11","author":"W Zhang","year":"2021","unstructured":"Zhang, W. et al. Cabazitaxel suppresses colorectal cancer cell growth via enhancing the p53 antitumor pathway. FEBS Open. Bio. 11 (11), 3032\u20133050. https:\/\/doi.org\/10.1002\/2211-5463.13290 (2021).","journal-title":"FEBS Open. Bio"},{"key":"59498_CR8","unstructured":"Cabazitaxel (Jevtana). Uses, Side Effects, Interactions, Pictures, Warnings & Dosing - WebMD. Accessed: Apr. 30, 2026. [Online]. Available: https:\/\/www.webmd.com\/drugs\/cabazitaxel-jevtana#sideeffects"},{"key":"59498_CR9","doi-asserted-by":"publisher","first-page":"153553","DOI":"10.1016\/j.phymed.2021.153553","volume":"86","author":"K Wang","year":"2021","unstructured":"Wang, K., Liu, W., Xu, Q., Gu, C. & Hu, D. Tenacissoside G synergistically potentiates inhibitory effects of 5-fluorouracil to human colorectal cancer. Phytomedicine 86, 153553. https:\/\/doi.org\/10.1016\/j.phymed.2021.153553 (2021).","journal-title":"Phytomedicine"},{"issue":"12","key":"59498_CR10","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1158\/1535-7163.MCT-08-0715","volume":"7","author":"J Ma","year":"2008","unstructured":"Ma, J. & Waxman, D. J. Combination of Anti-angiogenesis with Chemotherapy for More Effective Cancer Treatment. Mol. Cancer Ther. 7 (12), 3670\u20133684. https:\/\/doi.org\/10.1158\/1535-7163.MCT-08-0715 (2008).","journal-title":"Mol. Cancer Ther."},{"key":"59498_CR11","doi-asserted-by":"publisher","first-page":"629008","DOI":"10.3389\/fonc.2021.629008","volume":"11","author":"H Zhao","year":"2021","unstructured":"Zhao, H., Zhang, X., Wang, M., Lin, Y. & Zhou, S. Stigmasterol Simultaneously Induces Apoptosis and Protective Autophagy by Inhibiting Akt\/mTOR Pathway in Gastric Cancer Cells. Front. Oncol. 11, 629008. https:\/\/doi.org\/10.3389\/fonc.2021.629008 (2021).","journal-title":"Front. Oncol."},{"key":"59498_CR12","doi-asserted-by":"publisher","unstructured":"Valitova, J., Renkova, A., Beckett, R. & Minibayeva, F. Stigmasterol: An Enigmatic Plant Stress Sterol with Versatile Functions. Int. J. Mol. Sci. 25 (15). https:\/\/doi.org\/10.3390\/ijms25158122 (2024).","DOI":"10.3390\/ijms25158122"},{"key":"59498_CR13","doi-asserted-by":"publisher","unstructured":"Zhang, X. et al. Advances in Stigmasterol on its anti-tumor effect and mechanism of action. Front. Oncol. 12 https:\/\/doi.org\/10.3389\/fonc.2022.1101289 (2022).","DOI":"10.3389\/fonc.2022.1101289"},{"issue":"9","key":"59498_CR14","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1039\/D3NJ04057G","volume":"48","author":"N Bhardwaj","year":"2024","unstructured":"Bhardwaj, N. et al. Isolation of cytotoxic cycloartane triterpenoids from Dysoxylum malabaricum. New. J. Chem. 48 (9), 3933\u20133941. https:\/\/doi.org\/10.1039\/D3NJ04057G (2024).","journal-title":"New. J. Chem."},{"key":"59498_CR15","doi-asserted-by":"publisher","first-page":"177361","DOI":"10.1016\/j.ejphar.2025.177361","volume":"992","author":"S Singh","year":"2025","unstructured":"Singh, S. et al. Synergistic combination of doxorubicin with fisetin for the treatment of lymphoma. Eur. J. Pharmacol. 992, 177361. https:\/\/doi.org\/10.1016\/j.ejphar.2025.177361 (2025).","journal-title":"Eur. J. Pharmacol."},{"key":"59498_CR16","doi-asserted-by":"crossref","unstructured":"SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples | Nucleic Acids Research | Oxford Academic. Accessed: Apr. 30, [Online]. (2026). Available: https:\/\/academic.oup.com\/nar\/article\/50\/W1\/W739\/6586861","DOI":"10.1093\/nar\/gkac382"},{"key":"59498_CR17","doi-asserted-by":"publisher","first-page":"118537","DOI":"10.1016\/j.jep.2024.118537","volume":"334","author":"P Goswami","year":"2024","unstructured":"Goswami, P. et al.Mitochondria mediated inhibitory effect of Nyctanthes arbor-tristis (L.) flower extract against breast adenocarcinoma and T-cell lymphoma: An in vitro and in vivo study.J. Ethnopharmacol. 334, 118537. https:\/\/doi.org\/10.1016\/j.jep.2024.118537 (2024).","journal-title":"J. Ethnopharmacol."},{"key":"59498_CR18","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.biopha.2017.01.044","volume":"88","author":"G Sharma","year":"2017","unstructured":"Sharma, G. et al. p53 dependent apoptosis and cell cycle delay induced by heteroleptic complexes in human cervical cancer cells. Biomed. Pharmacother. 88, 218\u2013231. https:\/\/doi.org\/10.1016\/j.biopha.2017.01.044 (2017).","journal-title":"Biomed. Pharmacother"},{"issue":"5","key":"59498_CR19","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1038\/nprot.2006.339","volume":"1","author":"NAP Franken","year":"2006","unstructured":"Franken, N. A. P., Rodermond, H. M., Stap, J., Haveman, J. & van Bree, C. Clonogenic assay of cells in vitro. Nat. Protoc. 1 (5), 2315\u20132319. https:\/\/doi.org\/10.1038\/nprot.2006.339 (2006).","journal-title":"Nat. Protoc."},{"issue":"3","key":"59498_CR20","doi-asserted-by":"publisher","first-page":"e202403454","DOI":"10.1002\/chem.202403454","volume":"31","author":"A Kumar Yadav","year":"2025","unstructured":"Kumar Yadav, A. et al. Sonodynamic Cancer Therapy by Mn(I)-tricarbonyl Complexes via Ultrasound-triggered CO Release and ROS Generation. Chemistry 31 (3), e202403454. https:\/\/doi.org\/10.1002\/chem.202403454 (2025).","journal-title":"Chemistry"},{"key":"59498_CR21","doi-asserted-by":"publisher","first-page":"153408","DOI":"10.1016\/j.phymed.2020.153408","volume":"81","author":"J Shi","year":"2021","unstructured":"Shi, J. et al. Synergistic breast cancer suppression efficacy of doxorubicin by combination with glycyrrhetinic acid as an angiogenesis inhibitor. Phytomedicine 81, 153408. https:\/\/doi.org\/10.1016\/j.phymed.2020.153408 (2021).","journal-title":"Phytomedicine"},{"key":"59498_CR22","doi-asserted-by":"publisher","unstructured":"Aare, M. et al. Synergistic Anticancer Activity of Cannabinoids and Terpenes Against Triple-Negative Breast Cancer Resistance. Int. J. Mol. Sci. 27 (6). https:\/\/doi.org\/10.3390\/ijms27062730 (2026).","DOI":"10.3390\/ijms27062730"},{"issue":"3","key":"59498_CR23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3329\/bjsir.v54i3.42680","volume":"54","author":"MM Haque","year":"2019","unstructured":"Haque, M. M., Sultana, N., Abedin, S. M. T. & Kabir, S. E. Stigmasterol, rengyolone, 2-phenylethyl \u03b2-D-glucopyranoside and n-tetradecyl-\u03b2-D-glucopyranoside from the flowers of Nyctanthes arbor-tristis Linn. Bangladesh J. Sci. Industrial Res. 54 (3), 275\u2013282. https:\/\/doi.org\/10.3329\/bjsir.v54i3.42680 (2019).","journal-title":"Bangladesh J. Sci. Industrial Res."},{"key":"59498_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jnutbio.2016.03.003","volume":"33","author":"A Zafar","year":"2016","unstructured":"Zafar, A., Singh, S. & Naseem, I. Cu(II)-coumestrol interaction leads to ROS-mediated DNA damage and cell death: a putative mechanism for anticancer activity. J. Nutr. Biochem. 33, 15\u201327. https:\/\/doi.org\/10.1016\/j.jnutbio.2016.03.003 (2016).","journal-title":"J. Nutr. Biochem."},{"issue":"1","key":"59498_CR25","doi-asserted-by":"publisher","first-page":"e21148","DOI":"10.1096\/fj.202001693R","volume":"35","author":"A Rovini","year":"2021","unstructured":"Rovini, A. et al. Quantitative analysis of mitochondrial membrane potential heterogeneity in unsynchronized and synchronized cancer cells. FASEB J. 35 (1), e21148. https:\/\/doi.org\/10.1096\/fj.202001693R (2021).","journal-title":"FASEB J."},{"key":"59498_CR26","unstructured":"Hammerman, P., Wong, K. K. & Gray, N. S. Combination therapy of transcription inhibitors and kinase inhibitors, WO2016201370A1, Dec. 15, 2016 Accessed: May 01, 2026. [Online]. Available: https:\/\/patents.google.com\/patent\/WO2016201370A1\/en"},{"key":"59498_CR27","doi-asserted-by":"publisher","first-page":"118187","DOI":"10.1016\/j.jep.2024.118187","volume":"330","author":"K Belhouala","year":"2024","unstructured":"Belhouala, K., Pandiella, A. & Benarba, B. Synergistic effects of medicinal plants in combination with spices from algeria: Anticancer, antiangiogenic activities, and embrytoxicity studies. J. Ethnopharmacol. 330, 118187. https:\/\/doi.org\/10.1016\/j.jep.2024.118187 (2024).","journal-title":"J. Ethnopharmacol."},{"key":"59498_CR28","doi-asserted-by":"publisher","unstructured":"Zhou, X. et al. The potential role of plant secondary metabolites on antifungal and immunomodulatory effect. Appl. Microbiol. Biotechnol. 1\u201322. https:\/\/doi.org\/10.1007\/s00253-023-12601-5 (2023).","DOI":"10.1007\/s00253-023-12601-5"},{"key":"59498_CR29","doi-asserted-by":"publisher","unstructured":"Zhou, H. et al. Research Progress on the Synergistic Anti-Tumor Effect of Natural Anti-Tumor Components of Chinese Herbal Medicine Combined with Chemotherapy Drugs. Pharmaceuticals 16 (12). https:\/\/doi.org\/10.3390\/ph16121734 (2023).","DOI":"10.3390\/ph16121734"},{"issue":"8","key":"59498_CR30","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.3390\/antibiotics11081014","volume":"11","author":"N Vaou","year":"2022","unstructured":"Vaou, N. et al. Interactions between Medical Plant-Derived Bioactive Compounds: Focus on Antimicrobial Combination Effects. Antibiot. (Basel). 11 (8), 1014. https:\/\/doi.org\/10.3390\/antibiotics11081014 (2022).","journal-title":"Antibiot. (Basel)"},{"issue":"5","key":"59498_CR31","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3109\/10715761003667554","volume":"44","author":"GY Liou","year":"2010","unstructured":"Liou, G. Y. & Storz, P. Reactive oxygen species in cancer. Free Radic Res. 44 (5), 479\u2013496. https:\/\/doi.org\/10.3109\/10715761003667554 (2010).","journal-title":"Free Radic Res."},{"issue":"2","key":"59498_CR32","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/bjc.2013.334","volume":"109","author":"J Wan","year":"2013","unstructured":"Wan, J. et al. Synergistic antitumour activity of sorafenib in combination with tetrandrine is mediated by reactive oxygen species (ROS)\/Akt signaling. Br. J. Cancer. 109 (2), 342\u2013350. https:\/\/doi.org\/10.1038\/bjc.2013.334 (2013).","journal-title":"Br. J. Cancer"},{"key":"59498_CR33","doi-asserted-by":"publisher","unstructured":"Kadenbach, B., Arnold, S., Lee, I. & H\u00fcttemann, M. The possible role of cytochrome c oxidase in stress-induced apoptosis and degenerative diseases, Biochimica et Biophysica Acta (BBA) - Bioenergetics, vol. 1655, pp. 400\u2013408, (2004). https:\/\/doi.org\/10.1016\/j.bbabio.2003.06.005","DOI":"10.1016\/j.bbabio.2003.06.005"},{"key":"59498_CR34","doi-asserted-by":"publisher","unstructured":"Abramov, A. Y. & Duchen, M. R. Mechanisms underlying the loss of mitochondrial membrane potential in glutamate excitotoxicity, Biochimica et Biophysica Acta (BBA) - Bioenergetics, vol. 1777, no. 7, pp. 953\u2013964, (2008). https:\/\/doi.org\/10.1016\/j.bbabio.2008.04.017","DOI":"10.1016\/j.bbabio.2008.04.017"},{"issue":"3","key":"59498_CR35","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s003940050054","volume":"38","author":"S Kuntz","year":"1999","unstructured":"Kuntz, S., Wenzel, U. & Daniel, H. Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines. Eur. J. Nutr. 38 (3), 133\u2013142. https:\/\/doi.org\/10.1007\/s003940050054 (1999).","journal-title":"Eur. J. Nutr."},{"key":"59498_CR36","doi-asserted-by":"publisher","first-page":"153109","DOI":"10.1016\/j.phymed.2019.153109","volume":"66","author":"JM Ku","year":"2020","unstructured":"Ku, J. M. et al. Synergistic anticancer effect of combined use of Trichosanthes kirilowii with cisplatin and pemetrexed enhances apoptosis of H1299 non-small-cell lung cancer cells via modulation of ErbB3. Phytomedicine 66, 153109. https:\/\/doi.org\/10.1016\/j.phymed.2019.153109 (2020).","journal-title":"Phytomedicine"},{"issue":"1","key":"59498_CR37","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1186\/s12935-021-02396-8","volume":"21","author":"HE Marei","year":"2021","unstructured":"Marei, H. E. et al. p53 signaling in cancer progression and therapy. Cancer Cell. Int. 21 (1), 703. https:\/\/doi.org\/10.1186\/s12935-021-02396-8 (2021).","journal-title":"Cancer Cell. Int."},{"issue":"1","key":"59498_CR38","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s13046-017-0647-5","volume":"36","author":"M Terranova-Barberio","year":"2017","unstructured":"Terranova-Barberio, M. et al. Synergistic antitumor interaction between valproic acid, capecitabine and radiotherapy in colorectal cancer: critical role of p53. J. Exp. Clin. Cancer Res. 36 (1), 177. https:\/\/doi.org\/10.1186\/s13046-017-0647-5 (2017).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"59498_CR39","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.devcel.2011.06.017","volume":"21","author":"JC Martinou","year":"2011","unstructured":"Martinou, J. C. & Youle, R. J. Mitochondria in Apoptosis: Bcl-2 Family Members and Mitochondrial Dynamics. Dev. Cell. 21 (1), 92\u2013101. https:\/\/doi.org\/10.1016\/j.devcel.2011.06.017 (2011).","journal-title":"Dev. Cell"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59498-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59498-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59498-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:52:00Z","timestamp":1790117520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59498-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["59498"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-59498-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"17 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors are giving their consent to publish an original research article entitled \u201cMolecular Insights into the Synergistic Anticancer Effect of Stigmasterol and Cabazitaxel in Colon Cancer through ROS-Mediated Mitochondrial Dysfunction and Apoptosis\u201d for publication in Scientific Reports.","order":2,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"29525"}}